Twist Bioscience Corporation (TWST) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Twist Bioscience Corporat... (TWST)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

45.33

2.58 (6.04%)

At close: Jan 15, 2025, 3:59 PM

45.48

0.33%

After-hours Jan 15, 2025, 04:00 PM EST

undefined% (undefined)

Bid	40.71
Market Cap	2.70B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-3.6
PE Ratio (ttm)	-12.59
Forward PE	n/a
Analyst	Buy

Ask	48
Volume	601,001
Avg. Volume (20D)	788,021
Open	45.00
Previous Close	42.75
Day's Range	44.74 - 47.28
52-Week Range	27.41 - 60.90
Beta	undefined

About TWST

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration ...

[Show more]

Industry Medical - Diagnostics & Research

Sector Healthcare

IPO Date Oct 31, 2018

Employees 919

Stock Exchange NASDAQ

Ticker Symbol TWST

Website https://www.twistbioscience.com

Analyst Forecast

According to 9 analyst ratings, the average rating for TWST stock is "Buy." The 12-month stock price forecast is $54.5, which is an increase of 20.23% from the latest price.

Buy 88.89%

Hold 0.00%

Sell 11.11%

Stock Forecasts

Next Earnings Release

Twist Bioscience Corporation is scheduled to release its earnings on Jan 31, 2025, before market opens.
Analysts project revenue of $85.27M, reflecting a 19.26% YoY growth and earnings per share of -0.65, making a -13.33% decrease YoY.

Why Price Moved

1 month ago · Source

+9.87%

Twist Bioscience shares are trading higher after L... Unlock content with Pro Subscription

1 month ago · Source

+12.31%

Twist Bioscience shares are trading higher after the company reported better-than-expected Q4 EPS and sales.

News

2 weeks ago · zacks.com

All You Need to Know About Twist Bioscience (TWST) Rating Upgrade to Buy

Twist Bioscience (TWST) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

3 weeks ago · zacks.com

Twist Bioscience (TWST) Surges 9.9%: Is This an Indication of Further Gains?

Twist Bioscience (TWST) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near ...

3 weeks ago · businesswire.com

Twist Bioscience to Present at 43rd Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announce...

1 month ago · zacks.com

Twist Bioscience (TWST) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

After losing some value lately, a hammer chart pattern has been formed for Twist Bioscience (TWST), indicating that the stock has found support. This, combined with an upward trend in earnings estimat...

1 month ago · seekingalpha.com

Twist Bioscience: Path To Profitability Beginning To Take Shape

Twist Bioscience's SynBio and NGS segments continue to generate strong growth, despite macro challenges. The prospects of the biopharma segment are uncertain, highlighted by the sale of milestones and...

1 month ago · seekingalpha.com

Twist Bioscience: A Post-Earnings Assessment

Twist Biosciences just posted a solid Q4, which had the stock rising in trading Monday. However, despite impressive sales growth, Twist Biosciences remains unprofitable, with projected losses for seve...

1 month ago · benzinga.com

Twist Bioscience's Q4 Earnings And Q1 Guidance Surpass Expectations, Stock Jumps

On Monday, Twist Bioscience Corporation TWST reported a fourth-quarter loss per share of 59 cents, beating the consensus loss of 70 cents.

1 month ago · seekingalpha.com

Twist Bioscience Corporation (TWST) Q4 2024 Earnings Call Transcript

Twist Bioscience Corporation (NASDAQ:TWST ) Q4 2024 Earnings Conference Call November 18, 2024 8:00 AM ET Company Participants Angela Bitting - SVP, Corporate Affairs Emily Leproust - CEO and Co-Found...

1 month ago · zacks.com

Twist Bioscience (TWST) Reports Q4 Loss, Tops Revenue Estimates

Twist Bioscience (TWST) came out with a quarterly loss of $0.59 per share versus the Zacks Consensus Estimate of a loss of $0.73. This compares to loss of $0.81 per share a year ago.

1 month ago · businesswire.com

Twist Bioscience Announces Fiscal 2024 Fourth Quarter and Full Year Financial Results

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today ...

2 months ago · seekingalpha.com

Twist Bioscience's Earnings Preview: Partnerships And Valuation Make It A 'Buy'

Since I last covered it, Twist Bioscience has made significant strides. They have secured new partnerships, launched innovative products, and secured strategic financial agreements. TWST's valuation m...

2 months ago · businesswire.com

Twist Bioscience Launches FlexPrep™ Ultra-High Throughput Library Preparation Kit for Applications in Agrigenomics and Population Genomics

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...